Cite
HARVARD Citation
Lickliter, J. et al. (n.d.). Safety and Pharmacokinetics (PK) in Humans of Intravenous ETX2514, a β-lactamase Inhibitor (BLI) which Broadly Inhibits Ambler Class A, C, and D β-lactamases. Open forum infectious diseases. p. S524. [Online].